| Delaware | 001-42841 | 45-5372621 | ||||||
|
(State or other jurisdiction of
incorporation or organization)
|
(Commission File Number) |
(I.R.S. Employer Identification Number) |
||||||
114 5th Ave, 17th Floor, New York, NY |
10011 | |||||||
| (Address of Principal Executive Offices) | (Zip Code) | |||||||
(917) 877-0915 | ||||||||
(Registrant's telephone number, including area code) | ||||||||
| Not applicable | ||||||||
(Former name or former address, if changed since last report.) | ||||||||
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
||||
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
||||
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
||||
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
||||
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
| Class A common stock, par value $0.00001 per share | VIA | New York Stock Exchange | ||||||
| Exhibit No. | Description | |||||||
| 99.1 | ||||||||
104 |
Cover Page Interactive Data File (embedded within the Inline XBRL document) |
|||||||
Via Transportation, Inc. |
||||||||
Dated: February 27, 2026 |
By: |
/s/ Daniel Ramot |
||||||
| Name: | Daniel Ramot | |||||||
| Title: |
Chief Executive Officer
(Principal Executive Officer)
|
|||||||
| Q4 2025 | Q4 2024 | Change | |||||||||||||||
| (in thousands, except percentages and customer count) | |||||||||||||||||
| Key Business Metrics: | |||||||||||||||||
Platform Annual Run-Rate Revenue (1) |
$ | 475,636 | $ | 366,736 | 30 | % | |||||||||||
Customer Count (2) |
821 | 665 | 23 | % | |||||||||||||
| Financial Highlights: | |||||||||||||||||
| Revenue | $ | 118,909 | $ | 91,684 | 30 | % | |||||||||||
| Gross Profit | $ | 46,953 | $ | 36,979 | 27 | % | |||||||||||
Adjusted Gross Profit (3) |
$ | 47,404 | $ | 37,649 | 26 | % | |||||||||||
Adjusted Gross Margin (3) |
40 | % | 41 | % | (1) | pt | |||||||||||
Adjusted EBITDA (3) |
$ | (7,384) | $ | (8,906) | N/M | ||||||||||||
Adjusted EBITDA Margin (3) |
(6) | % | (10) | % | 4 | pts | |||||||||||
| Net Loss | $ | (21,936) | $ | (18,898) | N/M | ||||||||||||
Adjusted Net Loss (3) |
$ | (4,796) | $ | (10,264) | N/M | ||||||||||||
| FY 2025 | FY 2024 | Change | |||||||||||||||
| (in thousands, except percentages) | |||||||||||||||||
| Financial Highlights: | |||||||||||||||||
| Revenue | $ | 434,337 | $ | 337,630 | 29 | % | |||||||||||
| Platform Revenue | $ | 434,337 | $ | 330,841 | 31 | % | |||||||||||
| Gross Profit | $ | 171,800 | $ | 130,840 | 31 | % | |||||||||||
Adjusted Gross Profit (3) |
$ | 173,596 | $ | 133,508 | 30 | % | |||||||||||
Adjusted Gross Margin (3) |
40 | % | 40 | % | — | pt | |||||||||||
Adjusted EBITDA (3) |
$ | (33,394) | $ | (54,392) | N/M | ||||||||||||
Adjusted EBITDA Margin (3) |
(8) | % | (16) | % | 8 | pts | |||||||||||
| Net Loss | $ | (96,361) | $ | (90,552) | N/M | ||||||||||||
Adjusted Net Loss (3) |
$ | (31,865) | $ | (56,451) | N/M | ||||||||||||
| Q1 2026 | FY 2026 | ||||||||||
| Revenue | $123.3M - $123.8M | $542.9M - $545.1M | |||||||||
| YoY Growth % | 25.0% - 25.5% | 25.0% - 25.5% | |||||||||
Adjusted EBITDA (1) |
($7.25)M - ($6.75)M | ($12.5)M - ($7.5)M | |||||||||
Adjusted EBITDA Margin (1) |
(5.9)% - (5.5)% | (2.3)% - (1.4)% | |||||||||
| Profitability | Q4 2026 Adj. EBITDA > $0 | ||||||||||
| Three Months Ended December 31, | Year Ended December 31, | ||||||||||||||||||||||
| ($ in thousands) | 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||
| Revenue | $ | 118,909 | $ | 91,684 | $ | 434,337 | $ | 337,630 | |||||||||||||||
Cost of revenue (1)(2) |
71,956 | 54,705 | 262,537 | 206,790 | |||||||||||||||||||
| Gross profit | 46,953 | 36,979 | 171,800 | 130,840 | |||||||||||||||||||
| Operating expenses: | |||||||||||||||||||||||
Research and development (1) |
25,138 | 21,363 | 92,352 | 88,987 | |||||||||||||||||||
Sales and marketing (1) |
18,591 | 14,767 | 67,423 | 55,484 | |||||||||||||||||||
General and administrative (1)(2) |
27,615 | 17,704 | 88,641 | 70,265 | |||||||||||||||||||
| Total operating expenses | 71,344 | 53,834 | 248,416 | 214,736 | |||||||||||||||||||
| Operating loss | (24,391) | (16,855) | (76,616) | (83,896) | |||||||||||||||||||
| Interest income | 3,335 | 435 | 5,272 | 2,195 | |||||||||||||||||||
| Interest expense | (371) | (1,871) | (7,343) | (4,291) | |||||||||||||||||||
| Loss on extinguishment of convertible notes | — | — | (10,949) | — | |||||||||||||||||||
| Other income (expense), net | (122) | (298) | (4,204) | (2,670) | |||||||||||||||||||
| Loss before provision for income taxes | (21,549) | (18,589) | (93,840) | (88,662) | |||||||||||||||||||
| Provision for income taxes | (387) | (309) | (2,521) | (1,890) | |||||||||||||||||||
| Net loss | (21,936) | (18,898) | (96,361) | (90,552) | |||||||||||||||||||
| Net income (loss) attributable to noncontrolling interest | — | (112) | — | (271) | |||||||||||||||||||
| Net loss attributable to common stockholders | $ | (21,936) | $ | (18,786) | $ | (96,361) | $ | (90,281) | |||||||||||||||
| Three Months Ended December 31, | Year Ended December 31, | ||||||||||||||||||||||
| ($ in thousands) | 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||
| Cost of revenue | $ | 56 | $ | 58 | $ | 203 | $ | 227 | |||||||||||||||
| Research and development | 3,540 | 1,721 | 8,626 | 6,583 | |||||||||||||||||||
| Sales and marketing | 2,895 | 1,286 | 7,340 | 4,023 | |||||||||||||||||||
| General and administrative | 7,905 | 2,314 | 15,083 | 10,393 | |||||||||||||||||||
| Total | $ | 14,396 | $ | 5,379 | $ | 31,252 | $ | 21,226 | |||||||||||||||
| Three Months Ended December 31, | Year Ended December 31, | ||||||||||||||||||||||
| ($ in thousands) | 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||
| Cost of revenue | $ | 395 | $ | 612 | $ | 1,593 | $ | 2,441 | |||||||||||||||
| General and administrative | 690 | 794 | 3,065 | 3,174 | |||||||||||||||||||
| Total | $ | 1,085 | $ | 1,406 | $ | 4,658 | $ | 5,615 | |||||||||||||||
| December 31, 2025 |
December 31 2024 |
||||||||||
| ASSETS | |||||||||||
| CURRENT ASSETS: | |||||||||||
| Cash and cash equivalents | $ | 370,914 | $ | 77,905 | |||||||
Accounts receivable—net of allowance of $24 and $127 as of December 31, 2025 and December 31, 2024, respectively |
81,572 | 73,760 | |||||||||
| Prepaid expenses and other current assets | 17,065 | 11,537 | |||||||||
| Total current assets | 469,551 | 163,202 | |||||||||
| NONCURRENT ASSETS: | |||||||||||
| Restricted cash and cash equivalents | 1,171 | 1,084 | |||||||||
| Property and equipment—net | 13,395 | 11,189 | |||||||||
| Operating lease right-of-use assets | 18,319 | 15,193 | |||||||||
| Deferred tax assets | 529 | 401 | |||||||||
| Intangible assets—net | 36,025 | 26,324 | |||||||||
| Goodwill | 192,305 | 160,134 | |||||||||
| Other noncurrent assets | 1,800 | 1,242 | |||||||||
| Total noncurrent assets | 263,544 | 215,567 | |||||||||
| TOTAL ASSETS | $ | 733,095 | $ | 378,769 | |||||||
| December 31, 2025 |
December 31, 2024 |
||||||||||
| LIABILITIES, CONVERTIBLE PREFERRED STOCK, AND STOCKHOLDERS’ EQUITY (DEFICIT) | |||||||||||
| CURRENT LIABILITIES: | |||||||||||
| Accounts payable | $ | 4,427 | $ | 3,915 | |||||||
| Accrued expenses and other current liabilities | 24,886 | 19,345 | |||||||||
| Operating lease liabilities | 9,749 | 8,307 | |||||||||
| Deferred revenue | 26,893 | 22,644 | |||||||||
| Insurance payables | 15,144 | 12,186 | |||||||||
| Accrued compensation and benefits | 13,136 | 10,152 | |||||||||
| Total current liabilities | 94,235 | 76,549 | |||||||||
| NONCURRENT LIABILITIES: | |||||||||||
| Operating lease liabilities | 9,378 | 7,264 | |||||||||
| Line of credit | — | 35,000 | |||||||||
| Convertible notes | — | 32,035 | |||||||||
| Derivatives liability | — | 18,819 | |||||||||
| Deferred revenue | 1,746 | 1,899 | |||||||||
| Total noncurrent liabilities | 11,124 | 95,017 | |||||||||
| Total liabilities | 105,359 | 171,566 | |||||||||
| CONVERTIBLE PREFERRED STOCK, $0.00001 PAR VALUE | — | 1,195,058 | |||||||||
| STOCKHOLDERS’ EQUITY (DEFICIT): | |||||||||||
| Preferred stock | — | — | |||||||||
Common stock |
— | — | |||||||||
Class A common stock |
1 | — | |||||||||
Class B common stock |
— | — | |||||||||
Class C common stock |
— | — | |||||||||
| Additional paid-in capital | 1,811,349 | 109,447 | |||||||||
| Accumulated other comprehensive income (loss) | 7,702 | (1,584) | |||||||||
| Accumulated deficit | (1,191,316) | (1,094,955) | |||||||||
Total stockholders’ equity (deficit) attributable to stockholders of Via |
627,736 | (987,092) | |||||||||
| Noncontrolling interest | — | (763) | |||||||||
| Total stockholders’ equity (deficit) | 627,736 | (987,855) | |||||||||
TOTAL LIABILITIES, CONVERTIBLE PREFERRED STOCK, AND STOCKHOLDERS’ EQUITY (DEFICIT) |
$ | 733,095 | $ | 378,769 | |||||||
| Three Months Ended December 31, | Year Ended December 31, | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| OPERATING ACTIVITIES: | |||||||||||||||||||||||
| Net loss | $ | (21,936) | $ | (18,898) | $ | (96,361) | $ | (90,552) | |||||||||||||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||||||||||||||||||||
| Depreciation and amortization | 2,053 | 2,219 | 8,529 | 9,126 | |||||||||||||||||||
| Stock-based compensation | 14,396 | 5,379 | 30,341 | 21,226 | |||||||||||||||||||
| Provision for deferred taxes | 655 | 32 | (120) | 222 | |||||||||||||||||||
| Noncash operating lease expense | 2,609 | 1,781 | 9,041 | 6,073 | |||||||||||||||||||
| Revaluation of warrants liability | — | 1,174 | (2,273) | 4,500 | |||||||||||||||||||
| Revaluation of convertible notes' embedded derivative feature | — | 370 | 9,312 | 370 | |||||||||||||||||||
| Amortization of convertible notes' discount | — | 814 | 4,819 | 814 | |||||||||||||||||||
Loss on extinguishment of convertible notes |
— | — | 10,949 | — | |||||||||||||||||||
| Changes in operating assets and liabilities: | |||||||||||||||||||||||
| Accounts receivable | 6,615 | (5,441) | (1,700) | (15,554) | |||||||||||||||||||
| Prepaid expenses and other assets | (2,058) | (305) | (4,642) | (68) | |||||||||||||||||||
| Accounts payable | (1,891) | (4,710) | (324) | (2,709) | |||||||||||||||||||
| Accrued expenses and other current liabilities | 1,656 | (185) | 4,156 | 1,552 | |||||||||||||||||||
| Operating lease liabilities | (1,920) | (1,465) | (8,461) | (6,521) | |||||||||||||||||||
| Deferred revenue | 272 | (760) | 359 | 596 | |||||||||||||||||||
| Accrued compensation and benefits | (299) | 916 | 2,547 | (914) | |||||||||||||||||||
| Insurance payables | (607) | 1,425 | 2,959 | 1,877 | |||||||||||||||||||
| Net cash used in operating activities | (455) | (17,654) | (30,869) | (69,962) | |||||||||||||||||||
| INVESTING ACTIVITIES: | |||||||||||||||||||||||
| Purchase of property and equipment | (326) | (217) | (1,663) | (1,079) | |||||||||||||||||||
| Capitalized internal-use software | (1,029) | (876) | (4,251) | (3,372) | |||||||||||||||||||
Acquisitions—net of cash acquired |
(39,892) | — | (39,892) | — | |||||||||||||||||||
| Net cash used in investing activities | (41,247) | (1,093) | (45,806) | (4,451) | |||||||||||||||||||
| FINANCING ACTIVITIES: | |||||||||||||||||||||||
| Proceeds from issuance of Series E convertible preferred stock upon exercise of warrants | — | — | 20,000 | — | |||||||||||||||||||
| Proceeds from line of credit | — | — | — | 40,000 | |||||||||||||||||||
| Repayment of line of credit | (25,000) | (5,000) | (35,000) | (5,000) | |||||||||||||||||||
| Proceeds from issuance of convertible notes | — | 42,500 | 7,500 | 42,500 | |||||||||||||||||||
| Proceeds from exercise of stock options | 3,794 | 1,576 | 13,746 | 2,828 | |||||||||||||||||||
Proceeds from initial public offering, net of underwriting discounts and commissions |
58,543 | — | 366,414 | — | |||||||||||||||||||
| Payments of initial public offering costs | (2,961) | — | (4,012) | — | |||||||||||||||||||
| Payment of issuance fees | — | (50) | (322) | (50) | |||||||||||||||||||
| Net cash provided by financing activities | 34,376 | 39,026 | 368,326 | 80,278 | |||||||||||||||||||
| EFFECT OF FOREIGN EXCHANGE ON CASH, CASH EQUIVALENTS, AND RESTRICTED CASH AND CASH EQUIVALENTS | 119 | (658) | 1,445 | (477) | |||||||||||||||||||
| NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH AND CASH EQUIVALENTS | (7,207) | 19,621 | 293,096 | 5,388 | |||||||||||||||||||
| CASH, CASH EQUIVALENTS, AND RESTRICTED CASH AND CASH EQUIVALENTS—Beginning of period | 379,292 | 59,368 | 78,989 | 73,601 | |||||||||||||||||||
| CASH, CASH EQUIVALENTS, AND RESTRICTED CASH AND CASH EQUIVALENTS—End of period | $ | 372,085 | $ | 78,989 | $ | 372,085 | $ | 78,989 | |||||||||||||||
| Three Months Ended December 31, | Year Ended December 31, | ||||||||||||||||||||||
| ($ in thousands) | 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||
| Gross profit | $ | 46,953 | $ | 36,979 | $ | 171,800 | $ | 130,840 | |||||||||||||||
| Gross profit margin | 39% | 40% | 40% | 39% | |||||||||||||||||||
| Stock-based compensation and related employer payroll taxes | 56 | 58 | 203 | 227 | |||||||||||||||||||
Amortization of acquired intangibles (1) |
395 | 612 | 1,593 | 2,441 | |||||||||||||||||||
| Adjusted Gross Profit | $ | 47,404 | $ | 37,649 | $ | 173,596 | $ | 133,508 | |||||||||||||||
| Adjusted Gross Margin | 40% | 41% | 40% | 40% | |||||||||||||||||||
| Three Months Ended December 31, | Year Ended December 31, | ||||||||||||||||||||||
| ($ in thousands) | 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||
| Net loss | $ | (21,936) | $ | (18,898) | $ | (96,361) | $ | (90,552) | |||||||||||||||
| Interest Income | (3,335) | (435) | (5,272) | (2,195) | |||||||||||||||||||
| Interest expense | 371 | 1,871 | 7,343 | 4,291 | |||||||||||||||||||
| Loss on extinguishment of convertible notes | — | — | 10,949 | — | |||||||||||||||||||
| Provision for income taxes | 387 | 309 | 2,521 | 1,890 | |||||||||||||||||||
Other (income) expense, net (1) |
122 | 298 | 4,204 | 2,670 | |||||||||||||||||||
Depreciation and amortization (2) |
1,460 | 1,819 | 6,264 | 7,530 | |||||||||||||||||||
| Stock-based compensation and related employer payroll taxes | 14,396 | 5,379 | 31,252 | 21,226 | |||||||||||||||||||
Patent litigation costs (3) |
311 | 398 | 2,909 | 310 | |||||||||||||||||||
Transaction costs (4) |
840 | 353 | 2,797 | 438 | |||||||||||||||||||
| Adjusted EBITDA | $ | (7,384) | $ | (8,906) | $ | (33,394) | $ | (54,392) | |||||||||||||||
| Net loss margin | (18)% | (21)% | (22)% | (27)% | |||||||||||||||||||
| Adjusted EBITDA Margin | (6)% | (10)% | (8)% | (16)% | |||||||||||||||||||
| Three Months Ended December 31, | Year Ended December 31, | ||||||||||||||||||||||
| ($ in thousands) | 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||
| GAAP research and development expense | $ | 25,138 | $ | 21,363 | $ | 92,352 | $ | 88,987 | |||||||||||||||
| Depreciation | (118) | (147) | (513) | (795) | |||||||||||||||||||
| Stock-based compensation and related employer payroll taxes | (3,540) | (1,721) | (8,626) | (6,583) | |||||||||||||||||||
Transaction costs (1) |
(162) | — | (351) | — | |||||||||||||||||||
| Adjusted Research and Development expense | $ | 21,318 | $ | 19,495 | $ | 82,862 | $ | 81,609 | |||||||||||||||
| GAAP sales and marketing expense | $ | 18,591 | $ | 14,767 | $ | 67,423 | $ | 55,484 | |||||||||||||||
| Stock-based compensation and related employer payroll taxes | (2,895) | (1,286) | (7,340) | (4,023) | |||||||||||||||||||
Transaction costs (1) |
(60) | — | (373) | — | |||||||||||||||||||
| Adjusted Sales and Marketing expense | $ | 15,636 | $ | 13,481 | $ | 59,710 | $ | 51,461 | |||||||||||||||
| GAAP general and administrative expense | $ | 27,615 | $ | 17,704 | $ | 88,641 | $ | 70,265 | |||||||||||||||
| Depreciation and amortization | (947) | (1,064) | (4,158) | (4,312) | |||||||||||||||||||
| Stock-based compensation and related employer payroll taxes | (7,905) | (2,314) | (15,083) | (10,393) | |||||||||||||||||||
Patent litigation costs (2) |
(311) | (398) | (2,909) | (310) | |||||||||||||||||||
Transaction costs (1) |
(618) | (353) | (2,073) | (438) | |||||||||||||||||||
| Adjusted General and Administrative expense | $ | 17,834 | $ | 13,575 | $ | 64,418 | $ | 54,812 | |||||||||||||||
| Three Months Ended December 31, | Year Ended December 31, | ||||||||||||||||||||||
| ($ in thousands) | 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||
| GAAP net loss | $ | (21,936) | $ | (18,898) | $ | (96,361) | $ | (90,552) | |||||||||||||||
| Amortization of discount on convertible notes | — | 800 | 4,819 | 800 | |||||||||||||||||||
| Loss on extinguishment of convertible notes | — | — | 10,949 | — | |||||||||||||||||||
| Revaluation of warrants liability | — | 1,174 | (2,273) | 4,500 | |||||||||||||||||||
| Revaluation of convertible notes embedded derivative feature | — | 370 | 9,312 | 370 | |||||||||||||||||||
| Employee retention credit | (231) | (1,857) | (2,483) | (1,857) | |||||||||||||||||||
Depreciation and amortization (1) |
1,460 | 1,819 | 6,264 | 7,530 | |||||||||||||||||||
| Stock-based compensation and related employer payroll taxes | 14,396 | 5,379 | 31,252 | 21,226 | |||||||||||||||||||
Patent litigation costs (2) |
311 | 398 | 2,909 | 310 | |||||||||||||||||||
Transaction costs (3) |
840 | 353 | 2,797 | 438 | |||||||||||||||||||
| Provision for income tax benefit of adjustments | 364 | 198 | 950 | 784 | |||||||||||||||||||
| Adjusted Net Loss | $ | (4,796) | $ | (10,264) | $ | (31,865) | $ | (56,451) | |||||||||||||||